M. V. Bilenko, Ischemic and Reperfusion Damage to Organs [in Russian], Meditsina, Moscow (1989).
A. G. Portnichenko, M. I. Vasilenko, and A. A. Moibenko, “The effects of acute hypoxic hypoxia on the induction of nitric oxide synthase in rats,” Fiziol. Zh., 49, No. 3, 47–49 (2003).
A. G. Portnichenko, M. I. Vasilenko,V. I. Portnichenko, and A. A. Moibenko, “Acute hypoxic hypoxia as an inducer of delayed cardioprotection in rats,” in: Hypoxia, Automated Analysis of Hypoxic States. Collected Studies [in Russian], A. Z. Kolchinskaya (ed.), Nalchik, Moscow (2005), Vol. 1, pp. 185–190.
A. G. Portnichenko, K. V. Rozova, M. I. Vasilenko, and O. O. Moibenko, “Age characteristics of ultrastructural changes in the myocardium in hypoxic preconditioning and ischemia-reperfusion of isolated rat hearts,” Fiziol. Zh., 53, No. 4, 27–34 (2007).
A. G. Portnichenko, M. I. Vasilenko, and O. O. Moibenko, “The role of potassium channels in the effector mechanisms of cardioprotection in late preconditioning of the rat heart,” Patologiya, 5, No. 3, 61–62 (2008).
A. G. Portnichenko, “The phenomenon of late preconditioning of the myocardium or phenotypic cardioprotection,” in: Endogenous Mechanisms of Cardioprotection as the Basis of the Pathogenetic Therapy of Heart Diseases [in Russian], A. A. Moibenko, V. E. Dosenko, and A. N. Parkhomenko (eds.), NVP Vidavnitstvo “Naukova Dumka,” Ukrainian National Academy of Sciences, Kiev (2008), pp. 305–331.
A. Aries, P. Paradis, C. Lefebvre, R. J. Schwartz, and M. Nemer, “Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity,” Proc. Natl. Acad. Sci. USA, 101, No. 18, 6975–6980 (2004).
M. A. Arstall, Y. Z. Zhao, L. Hornberger, S. P. Kennedy, R. A. Buchholz, R. Osathamondh, and R. A. Kelly, “Human ventricular myocytes in vitro exhibit both early and delayed preconditioning responses to simulated ischemia,” J. Mol. Cell. Cardiol., 30, No. 5, 1019–1025 (1998).
K. Ban, A. J. Cooper, S. Samuel, A. Bhatti, M. Patel, S. Izumo, J. M. Penninger, P. H. Backx, G. Y. Oudit, and R. G. Tsushima, “Phosphatidyinositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosine-mediated preconditioning,” Circ. Res., 103, No. 6, 643–653 (2008).
S. Banerjee, X. L. Tank, Y. Qiu, H. Takano, S. Manchikalapudi, B. Dawn, G. Shirk, and R. Bolli, “Nitroglycerin induces late preconditioning against myocardial stunning via a PKC-dependent pathway,” Am. J. Physiol., 277, No. 6, Part 2, H2488–H2494 (1999).
P. C. Beguin, M. Joyeux-Faure, D. Godin-Ribuot, P. Lévy, and C. Ribuot, “Acute intermittent hypoxia improves rat myocardium tolerance to ischemia,” J. Appl. Physiol., 99, No. 3, 1064–1069 (2005).
P. C. Beguin, E. Belaidi, D. Godin-Ribuot, P. Lévy, and C. Ribuot, “Intermittent hypoxia-induced delayed cardioprotection is mediated by PKC and triggered by p38 MAP kinase and Erk1/2,” J. Mol. Cell. Cardiol., 42, No. 2, 343–351 (2007).
I. J. Benjamin and D. R. McMillan, “Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease,” Circ. Res., 83, No. 2, 117–132 (1998).
M. Bernaudin and F. R. Sharp, “Methods to detect hypoxia-induced ischemic tolerance in the brain,” Meth. Enzymol., 381, 399–416 (2004).
W. M. Bernhardt, C. Warnecke, C. William, T. Tanaka, M. S. Wiesener, and K. U. Eckardt, “Organ protection by hypoxia and hypoxia-inducible factors,” Meth. Enzymol., 435, 221–245 (2007).
I. Bin-Jaliah, H. I. Ammar, D. P. Mikhailidis, M. A. Dallak, F. H. Al-Hashem, M. A. Haidara, H. Z. Yassin, A. A. Bahnasi, L. A. Rashed, and E. R. Isenovic, “Cardiac adaptive responses after hypoxia in an experimental model,” Angiology, 61, No. 2, 145–156 (2010).
Z. Cai, D. J. Manalo, G. Wei, E. R. Rodriguez, K. Fox-Talbot, H. Lu, J. L. Zweier, and G. L. Semenza, “Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury,” Circulation, 108, No. 1, 79–85 (2003).
Z. Cai, H. Zhong, M. Bosch-Marce, K. Fox-Talbot, L. Wang, C. Wei, M. A. Trush, and G. L. Semenza, “Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1α,” Cardiovasc. Res., 77, No. 3, 463–470 (2008).
F. Charron, G. Tsimiklis, M. Arcand, L. Robitaille, Q. Liang, J. D. Molkentin, S. Meloche, and M. Nemer, “Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA,” Genes Dev., 15, No. 20, 2702–2719 (2001).
H. P. Chen, M. He,Y. L. Xu, Q. R. Huang, G. H. Huang, G. H. Zeng, D. Liu, and Z. P. Liao, “Anoxic preconditioning up-regulates 14-3-3 protein expression in neonatal rat cardiomyocytes through extracellular signal-regulated kinase 1/2,” Life Sci., 81, No. 5, 372–379 (2007).
Y. Y. Chen and Q. Xia, “Evaluation of Gi/o protein signal transduction pathway in cardioprotection of hypoxic preconditioning,” Acta physiol. Sin., 52, No. 2, 93–97 (2000).
D. V. Cuong, N. Kim, J. B. Youm, H. Joo, M. Warda, J. W. Lee, W. S. Park, T. Kim, S. Kang, H. Kim, and J. Han, “Nitric oxidecGMP-protein kinase G signaling pathway induces anoxic preconditioning through activation of ATP-sensitive K + channels in rat hearts,” Am. J. Physiol. Heart Circ. Physiol., 290, No. 5, H1808–H1817 (2006).
B. Dawn and R. Bolli, “Role of nitric oxide in myocardial preconditioning,” Ann. N.Y. Acad. Sci., 962, 18–41 (2002).
T. Eckjle, D. Köhler, R. Lehmann, K. El Kasmi, and H. K. Eltzschig, “Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning,” Circulation, 118, No. 2, 166–175 (2008).
K. Z. Gong, Z. G. Zhang, A.H. Li, Y. F. Huang, P. Bu, F. Dong, and J. Liu, “ROS-mediated ERK activation in delayed protection from anoxic preconditioning in neonatal rat cardiomyocytes,” Chin. J. Med., 117, No. 3, 395–400 (2004).
Y. Honma, M. Tani, M. Takayama, K. Yamamura, and H. Hasegawa, “Aging abolishes the cardioprotective effect of combination heat shock and hypoxic preconditioning in reperfused rat hearts,” Basic Res. Cardiol., 67, No. 6, 489–495 (2002).
Y. F. Huang, K. Z. Gong, and A. G. Zhang, “Different roles of ERK1/2 and p38 MAPKα/β in cellular signaling during cardiomyocyte anoxia preconditioning,” Acta Physiol. Sin., 55, No. 4, 454–458 (2003).
J. D. Jiao, V. Garg, B. Yang, and K. Hu, “Novel functional role of heat shock protein 90 in ATP-sensitive K + channel-mediated hypoxic preconditioning,” Cardiovasc. Res., 77, No. 1, 126–133 (2008).
A. Kalota, S. E. Shetzline, and A. M. Gewirtz, “Progress in the development of nucleic acid therapeutics for cancer,” Cancer Biol. Ther., 3, No. 1, 4–12 (2004).
R. Kerkala, S. Pikkarainen, T. Majalahti-Palviainen, H. Tokola, and H. Ruskoako, “Distinct roles of mitogen-activated protein kinase pathways in GATA-4 transcription factor-mediated regulation of B-type natriuretic peptide gene,” J. Biol. Chem., 277, No. 16, 13752–13760 (2002).
J. Khoury, J. C. Ibla, A. S. Neish, and S. P. Colgun, “Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation,” J. Clin. Invest., 117, No. 3, 703–711 (2007).
Y. Kim, A. G. Ma, K. Kitta, S. N. Fitch, T. Ideka,Y. Ihara, A. R. Simon, T. Evans, and Y. J. Suzuki, “Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis,” Mol. Pharmacol., 63, No. 2, 368–377 (2003).
K. Kitta, S. A. Clément, J. Remeika, J. B. Blumberg, and Y. J. Suzuki, “Endothelin-1 induces phosphorylation of GATA-4 transcription factor in the HL-1 atrial-muscle cell line,” Biochem. J., 359, Part 2, 375–380 (2001).
K. Kitta, R. M. Day, Y. Kim, J. Torregroza, T. Evans, and Y. J. Suzuki, “Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells,” J. Biol. Chem., 278, No. 7, 4705–4712 (2003).
S. Kobayashi, T. Lackey,Y. Huang, E. Bisping,W. T. Pu, L. M. Boxer, and Q. Liang, “Transcription factor GATA4 regulates BCL2 gene expression in vitro and in vivo,” FASEB J., 20, No. 6, 800–802 (2006).
F. Kolar, J. Jezková, P. Balková, J. Breh, F. Neckár, F. Novák, O. Nováková, H. Tomásová, M. Srbová, B. Ost’ádal, J. Wilhelm, and J. Herget, “Role of oxidative stress in PKC-δ upregulation and cardioprotection induced by chronic intermittent hypoxia,” Am. J. Physiol. Heart Circ. Physiol., 292, No. 1, H224–H230 (2007).
G. Kroemer, L. Galluzzi, and C. Brenner, “Mitochondrial membrane permeabilization in cell death,” Physiol. Rev., 87, No. 1, 99–163 (2007).
J. Kurreck, “Antisense technologies. Improvement through novel chemical modifications,” Eur. J. Biochem., 270, No. 8, 1628–1644 (2003).
R. D. Lasley, G. M. Anderson, and R. M. Mentzer, “Ischaemic and hypoxic preconditioning enhance postischaemic recovery in the rat heart,” Cardiovasc. Res., 27, No. 4, 565–570 (1993).
X. Liu, X. Wu, L. Cai, C. Tang, and J. Su, “Hypoxic preconditioning of cardiomyocytes and cardioprotection: phosphorylation of HIF-1α induced by p42/p44 mitogen-activated protein kinases is involved,” Pathophysiology, 9, No. 4, 201–205 (2003).
L. D. Lukyanova, E. L. Germanova, and R. A. Kopaladze, “Development of resistance of an organism under various conditions of hypoxic preconditioning: role of the hypoxic period and reoxygenation,” Bull. Exp. Biol. Med., 147, No. 4, 400–404 (2009).
S. C. Masters, R. R. Subramanian, A. Truong, H. Yang, K. Fujii, H. Zhang, and H. Fu, “Survival-promoting functions of 14-3-3 proteins,” Biochem. Soc. Trans., 30, No. 4, 360–365 (2002).
N. Maulik, R. M. Engelman, J. A. Rousou, J. E. Flack, D. Deaton, and D. K. Das, “Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2,” Circulation, 100, No. 10, Supplement, II369–II375 (1999).
T. Morimoto, K. Hasegawa, T. Kakita, H. Wada, T. Yanazume, and S. Sasayama, “Phosphorylation of GATA-4 is involved in α1-adrenergic agonist-responsive transcription of the endothelin-1 gene in cardiac myocytes,” J. Biol. Chem., 275, No. 18, 13721–13726 (2000).
S. Munro, and H. R. Pelham, “An Hsp70-like protein in the ER: identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein,” Cell, 46, No. 2, 291–300 (1986).
M. Nojiri, K. Tanonaka, K. Yabe, K. Kawana, T. Iwai, M. Yamane, H. Yoshida, J. Hayashi, and S. Takeo, “Involvement of adenosine receptor, potassium channel and protein kinase C in hypoxic preconditioning of isolated cardiomyocytes of adult rat,” Jap. J. Pharmacol., 80, No. 1, 15–23 (1999).
M. Ogbi and J. A. Johnson, “Protein kinase Cε interacts with cytochrome oxidase subunit IV and enhances cytochrome c oxidase activity in neonatal cardiac myocyte preconditioning,” Biochem. J., 393, Part 1, 191–199 (2006).
B. Ostadal and F. Kolar, Cardiac Ischemia: from Injury to Protection, Kluwer Academic Publishers, Boston, Dordrecht, London (1999).
Y. X. Pan, L. Lin, A. J. Ren, H. Chen, C. S. Tang, and W. J. Yuan, “HSP70 and FRP78 induced by endothelin-1 pretreatment enhance tolerance to hypoxia in cultured neonatal rat cardiomyocytes,” J. Cardiovasc. Pharmacol., 44, Supplement 1, S117–S120 (2004).
Y. X. Pan, A. J. Ren, J. Zheng, W. F. Rong, H. Chen, X. H. Yan, C. Wu, W. J. Yuan, and L. Lin, “Delayed cytoprotection induced by hypoxic preconditioning in cultured neonatal rat cardiomyocytes: role of GRP78,” Life Sci., 81, No. 13, 1042–1049 (2007).
A. M. Park, H. Nagase, S. Vinod Kumar, and Y. J. Suzuki, “Acute intermittent hypoxia activates myocardial cell survival signaling,” Am. J. Physiol. Heart Circ. Physiol., 29, No. 2, H751–H757 (2007).
A. G. Portnychenko,V. E. Dosenko,V. I. Portnichenko, and O. O. Moybenko, “Expression of HIF-1α and HIF-3α differentially changed in rat heart ventricles after hypoxic preconditioning,” in : Proceedings of the XXVII European Section Meeting of the ISHR, Athens, Greece, May 28–31, 2008, Medimond Inter. Proc. (2008), pp. 61–64.
S. Rane, M. He, D. Sayed, H. Vashistha, A. Malhotra, J. Sadoshima, D. E. Vatner, S. F. Vatner, and M. Abdellatif, “Downregulation of miR-199a depresses hypoxia-inducible factor-1α and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes,” Circ. Res., 104, No. 7, 879–886 (2009).
T. Ravingerova, J. E. Løkebø, J. Munch-Ellingsen, R. Sundset, P. Tande, and K. Ytrehus, “Mechanism of hypoxic preconditioning in guinea pig papillary muscles,” Mol. Cell. Biochem., 186, No. 1–2, 53–60 (1998).
A. Rizvi, X. L. Tang, Y. Qiu, Y. T. Xuan, H. Takano, A. K. Jadoon, and R. Bolli, “Increased protein synthesis is necessary for the development of late preconditioning signal against myocardial stunning,” Am. J. Physiol., 277, No. 3, Part 2, H874–H884 (1999).
M. Rosenquist, “14-3-3 proteins in apoptosis,” Braz. J. Med. Biol. Res., 36, No. 4, 403–408 (2003).
G. L. Semenza, “HIF-1: mediator of physiological and pathophysiological responses to hypoxia,” J. Appl. Physiol., 88, No. 4, 1474–1480 (2000).
G. L. Semenza, P. H. Roth, H. M. Fang, and G. L. Wang, “Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1,” J. Biol. Chem., 269, No. 38, 23757–23763 (1994).
K. Shinmura,Y. T. Xuan, X. L. Tang, E. Kodani, H. Han,Y. Zhu, and R. Boli, “Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning,” Circ. Res., 90, No. 5, 602–608 (2002).
K. Shintani-Ishida, M. Nakajima, K. Uemura, and K. Yoshida, “Ischemic preconditioning protects cardiomyocytes against ischemic injury by inducing GRP78,” Biochem. Biophys. Res. Commun., 345, No. 4, 1600–1605 (2006).
Y. Shizukuda, R. T. Mallet, S. C. Lee, and H. F. Downey, “Hypoxic preconditioning of ischaemic canine myocardium,” Cardiovasc. Res., 26, No. 5, 534–542 (1992).
Y. Shizukuda, T. Iwamoto, R. T. Mallet, and H. F. Downey, “Hypoxic preconditioning attenuates stunning caused by repeated coronary artery occlusions in dog heart,” Cardiovasc. Res., 27, No. 4, 559–564 (1993).
D. Singh, A. Sharma, and M. Singh, “Effect of actinomycin D and cycloheximide on ischemic preconditioning-induced delayed cardioprotective effect in rats,” Indian J. Exp. Biol., 38, No. 10, 982–987 (2000).
A. Skyschally, P. van Caster, K. Boengler, P. Gres, J. Musiolik, D. Schilawa, R. Schulz, and G. Heusch, “Ischemic postconditioning in pigs: no causal role for RISK activation,” Circ. Res., 104, No. 1, 15–18 (2009).
L. H. Snoeckx, R. N. Cornelussen, F. A. van Nieuwenhoven, R. S. Reneman, and G. J. Van der Vusse, “Heat shock proteins and cardiovascular pathophysiology,” Physiol. Rev., 81, No. 4, 1461–1497 (2001).
R. R. Subramanian, S. C. Masters, H. Zhang, and H. Fu, “Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis,” Exp. Cell Res., 271, No. 1, 142–151 (2001).
H. Y. Sun, N. P. Wang, F. Kerendi, M. Halkos, H. Kin, R. A. Guyton, J. Vinten-Johansen, and Z. Q. Zhao, “Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation intracellular Ca2+ overload,” Am. J. Physiol. Heart Circ. Physiol., 288, No. 4, H1900–H1908 (2005).
M. Tani, Y. Suganuma, M. Takayama, H. Hasegawa, K. Shinmura, Y. Ebihara, and K. Tamaki, “Low concentrations of adenosine receptor blocker decrease protection by hypoxic preconditioning in ischemic rat hearts,” J. Mol. Cell. Cardiol., 30, No. 3, 617–626 (1998).
M. Tani, Y. Honma, M. Takayama, H. Hasegawa, K. Shinmura, Y. Ebihara, and K. Tamaki, “Loss of protection by hypoxic preconditioning in aging Fischer 344 rat hearts related to myocardial glycogen content and Na + imbalance,” Cardiovasc. Res., 41, No. 3, 594–602 (1999).
G. Testoni, S. Cerruti, P. Kade, M. Carregal, A. Varela, and E. A. Savino, “Effects of hypoxic preconditioning on the hypoxic-reoxygenated atria from fed and fasted rats,” J. Physiol. Biochem., 56, No. 4, 321–328 (2000).
T. Uchiyama, R. M. Engelman, N. Maulik, and D. K. Das, “Role of Akt signaling in mitochondrial survival pathways triggered by hypoxic preconditioning,” Circulation, 109, No. 24, 3042–3049 (2004).
T. L. Vanden Hoek, L. B. Becker, Z. Shao, C. Li, and P. T. Schumacker, “Reactive oxygen species released from mitochondria during brief hypoxia preconditioning in cardiomyocytes,” J. Biol. Chem., 273, No. 29, 18092–18098 (1998).
T. L. Vanden Hoek, L. B. Becker, Z. H. Zhao, C. Q. Li, and P. T. Schumacker, “Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion,” Circ. Res., 86, No. 5, 541–548 (2000).
H. C. Wang, H. F. Zhang, W. Y. Guo, H. Su, K. R. Zhang, Q. X. Li, W. Yan, X. L. Ma, B. L. Lopez, T. A. Christopher, and F. Gao, “Hypoxic preconditioning enhances the survival and inhibits apoptosis of cardiomyocytes following reoxygenation: role of peroxynitrite formation,” Apoptosis, 11, No. 8, 1453–1460 (2006).
D. Wasserfuhr, S. M. Cetin, J. Yang, P. Freitag, S. Frede, H. Jakob, and P. Massoudy, “Protection of the right ventricle from ischemia and reperfusion by preceding hypoxia,” Naunyn-Schmiedeberg’s Arch. Pharmacol., 378, No. 1, 27–32 (2008).
R. A. White, L. L. Dowler, L. M. Pasztor, L. L. Gatson, L. R. Adkison, S. V. Angelonik, and D. B. Wilson, “Assignment of the transcription factor GATA4 gene to human chromosome 8 and mouse chromosome 145: Gata4 is a candidate gene for Ds (disorganization),” Genomics, 27, No. 1, 20–26 (1995).
X. Wu, X. Liu, X. Zhu, and C. Tang, “Hypoxic preconditioning induces delayed cardioprotection through p38 MAPK-mediated calreticulin upregulation,” Shock, 27, No. 5, 572–577 (2007).
L. Xi, D. Tekin, E. Gursoy, F. Salloum, J. E. Levasseur, and R. C. Kukreja, “Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia,” Am. J. Physiol. Heart Circ. Physiol., 283, No. 1, H5–H12 (2002).
F. F. Xu, X. H. Liu, and L. R. Cai, “Role of hypoxia-inducible factor-1α in the prevention of cardiomyocyte injury induced by hypoxic preconditioning,” Acta Physiol. Sin., 56, No. 5, 609–614 (2004).
X. M. Yang, Y. Liu, N. Tandon, J. Kambayashi, J. M. Downey, and M. V. Cohen, “Attenuation of infarction in cynomolgus monkeys: preconditioning and postconditioning,” Basic Res. Cardiol., 105, No. 1, 119–128 (2010).
D. M. Yellon and J. M. Downey, “Preconditioning the myocardium: from cellular physiology to clinical cardiology,” Physiol. Rev., 83, No. 4, 1113–1151 (2003).
J. G. Zhuang, Y. Zhang, and Z. N. Zhou, “Hypoxic preconditioning upregulates KATP channels through activation of protein kinase C in rat ventricular myocytes,” Acta Pharmacol. Sin., 21, No. 9, 845–849 (2000).
X. M. Zhu, X. H. Liu, L. R. Cai, and F. F. Zu, “Hypoxic preconditioning induces endoplasmic reticulum stress-related cardioprotection mediated by p38 mitogen-activated protein kinase,” Acta Physiol. Sin., 58, No. 5, 463–470 (2006).